sr9009 peptide A pyrrolidinecarbamate compound that acts as a specific REV-ERB-α/β agonist - SR9009injectable dosage Sr9009, commonly known as Stenabolic Understanding SR9009 Peptide: A Comprehensive Overview

SR9009injectable Reddit SR9009 peptide, also widely recognized as Stenabolic, has emerged as a compound of significant interest within the scientific community due to its potent activity as a REV-ERB agonist. Developed by Professor Thomas Burris at the Scripps Research Institute, SR9009 is a synthetic REV-ERB agonist used for treatment with metabolic diseasesChemotherapeutic Effect of SR9009, a REV-ERB Agonist .... This compound is not a selective androgen receptor modulator (SARM), as sometimes miscategorized, but rather a small molecule which can act as a RevErb a/b agonist. Its mechanism of action centers on its ability to bind to and activate the REV-ERB alpha (α) and beta (β) nuclear receptors.SR9009 These receptors play a crucial role in regulating circadian rhythms, lipid metabolism, and glucose metabolismComment:SR9009 is an estrogen receptor β agonist[1]. ... For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of .... Research indicates that SR9009 improves both fatty acid oxidation and glucose metabolism, offering potential applications in diverse physiological processes.

The scientific literature highlights SR9009's multifaceted effects. As a REV-ERB agonist, it increases the constitutive repression of genes regulated by these receptors. This makes it a valuable tool for researchers investigating metabolic pathways and cellular energy balanceAlters circadian locomotor activity and core clock hypothalamic gene expression in mice. Induces weight loss in diet-induced obese mice. Brain penetrant.. Studies have demonstrated that SR9009 induces weight loss in diet-induced obese mice, suggesting its potential role in modulating body weight and fat accumulation. Its ability to influence metabolic processes extends to enhancing fatty acid oxidation and glucose metabolism, which could be beneficial for conditions related to metabolic dysfunction.Chronic low-dose REV-ERBs agonist SR9009 mitigates constant light ...

Furthermore, SR9009 has been shown to alter circadian locomotor activity and core clock hypothalamic gene expression in mice.Huma Peptide SR-9009 This effect underscores its impact on the body's internal clock, which governs sleep-wake cycles, hormone release, and other daily physiological rhythms. The compound is described as brain penetrant, implying it can cross the blood-brain barrier, further underscoring its potential to influence neurological and behavioral patterns.

While SR9009 is a research drug and its applications in humans are still under investigation, preclinical studies have explored its potential benefits. These include its use in managing metabolic diseases such as obesity and diabetes. The compound's influence on fatty acid oxidation and glucose metabolism positions it as a subject of interest for interventions aimed at improving metabolic health. Additionally, some research points towards its potential in improving athletic performance, although robust scientific evidence to support this specific use in humans is limited.

The chemical structure of SR9009 is described as a pyrrolidinecarbamate compound that acts as a specific REV-ERB-α/β agonist. It exhibits direct and reversible binding to these receptors, with reported IC50 values of 670 nM for REV-ERB-α and 800 nM for REV-ERB-β.SR9009is a synthetic REV-ERB agonist used for treatment with metabolic diseasessuch as obesity, bipolar, anxiety and depressive disorders. These binding affinities indicate its potency in activating the target receptors. It is important to note that SR9009 is typically supplied as a powder and is intended for research purposes only. Manufacturers emphasize that they do not sell to patients.

Emerging research also suggests that SR9009 may play a role in mitigating inflammationSR9009 | CAS NO.:1379686-30-2. Studies have indicated that SR9009 decreased inflammation (IL-6) in certain contexts, suggesting a potential anti-inflammatory effect. While some sources mention it as an estrogen receptor β agonist, its primary and most extensively studied mechanism of action is through REV-ERB agonism.

In summary, SR9009 peptide, or Stenabolic, is a potent synthetic REV-ERB agonist that profoundly impacts metabolic processes, circadian rhythms, and potentially inflammation. Its ability to improve fatty acid oxidation and glucose metabolism makes it a compelling subject for continued research into metabolic diseases and their management.SR9009is a synthetic, nonsteroidal compound that is a modulator of Toll-like receptor (TLR) signaling pathways. The TLR pathway is involved in the ... As a research drug, understanding its precise effects and potential applications remains an active area of scientific inquiry.SR9009 | Ligand page